Quest Diagnostics Posts 2 Percent Decline in Q1 Sales | GenomeWeb

NEW YORK (GenomeWeb) – Quest Diagnostics today reported that its first quarter sales declined around 2 percent year over year with reimbursement issues and an "unseasonably harsh winter" cited as factors for the decrease.

The Madison, NJ-based clinical lab and diagnostic information services firm reported revenues from continuing operations of $1.75 billion, down from $1.79 billion in the first quarter of 2013. It matched the consensus Wall Street estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.